Send us Feedback

Acorda Therapeutics (ACOR)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 278M 256M 319M 333M 325M
Short Term Investments 0 0 0 0 0
Accounts Receivable 21.5M 23.6M 23.2M 26.3M 23.3M
Inventories 28.7M 29.4M 19.2M 21.0M 28.6M
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 19.3M 18.4M 18.1M 16.9M 18.7M
Total Current Assets 348M 327M 379M 397M 395M
Property, Plant & Equipment 6.52M 14.3M 16.4M 16.7M 16.9M
Goodwill & Intangibles 8.95M 8.76M 9.28M 9.32M 9.45M
Other Long-term Assets 22.9M 52.8M 5.47M 5.25M 5.06M
Total Long-Term Assets 38.3M 75.8M 31.2M 168M 170M
Total Assets 386M 403M 410M 565M 565M
Accounts Payable 40.5M 47.9M 41.7M 58.3M 55.9M
Accrued Expenses 0 0 0 0 0
Short Term Debt 1.14M 1.14M 1.14M 1.14M 1.14M
Other Current Liabilities 39.2M 38.0M 37.9M 38.3M 38.7M
Total Current Liabilities 82.1M 88.4M 82.0M 98.9M 96.9M
Long Term Debt 0 0 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 84.9M 85.0M 82.9M 80.5M 76.9M
Total Long-term Liabilities 84.9M 85.0M 82.9M 80.5M 76.9M
Minority Interest 0 0 0 0 0
Total Liabilities 167M 173M 165M 179M 174M
Preferred Stock 0 0 0 0 0
Common Par 0 0 0 0 0
Additional Paid-In Capital 0 0 0 0 0
Retained Earnings 0 0 0 0 0
Treasury Stock 0 0 0 0 0
Other Equity 219M 230M 245M 386M 392M
Total Shareholder's Equity 219M 230M 245M 386M 392M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki